Anti-CMV Cellular Immunity Quantification Using an IGRA Test in Kidney Transplant récipients and Hemodialysis Patients, Comparison to Control Patients

2019-04-21 13:33:29 | BioPortfolio

Published on BioPortfolio: 2019-04-21T13:33:29-0400

Clinical Trials [34 Associated Clinical Trials listed on BioPortfolio]

Comparing Consistency of QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold for Latent Tuberculosis in Dialysis Population

In patients receiving long term dialysis, using new generation of QuantiFERON-TB Gold Plus can have less result variability in inter-experiment and serial follow up in comparing with Quant...

Clinical Evaluation of the QuantiFERON CMV Assay

Validate the use of the device in the clinical setting for assessing the risk of CMV Infection in SOT recipients after the completion of antiviral prophylaxis.

Quantiferon for Detection of Latent Tuberculosis in Healthcare Workers

The accuracy of tuberculin skin test (TST) for detecting latent tuberculosis is limited in countries with a high proportion of population having received vaccination with the BCG. We aim t...

Clinical Evaluation of Quantiferon-Monitor to Predict Outcomes in Solid Organ Transplant Recipients

The study will prospectively determine the clinical utility of non-pathogen specific cellular immunity assessment using the Quantiferon-Monitor to quantify the degree of immunosuppression....

Evaluation of the QuantiFERON-TB Test.

To compare the results of the investigational test to the currently approved QuantiFERON-TB Gold In-Tube test.

PubMed Articles [12 Associated PubMed Articles listed on BioPortfolio]

Serial Testing of Mycobacterium Tuberculosis Infection in Chinese Village Doctors by QuantiFERON-TB Gold Plus, QuantiFERON-TB Gold In-Tube and T-SPOT.TB.

To evaluate the performance of QuantiFERON-TB Gold Plus (QFT-Plus) on Mycobacterium tuberculosis (MTB) infection test among registered village doctors from China.

Performance and variability of QuantiFERON Gold Plus assay associated with phlebotomy type.

QuantiFERON Gold Plus (Plus) assay has two approved methods for blood collection: direct in-tube (Plus direct) or the transfer of blood from a lithium heparin tube (Plus transfer). Currently, there is...

Sensitivity and characteristics associated with positive QuantiFERON-TB Gold-Plus assay in children with confirmed tuberculosis.

Although QuantiFERON-TB Gold Plus (QFT-Plus), a new interferon-gamma release assay, has shown good performance in adults, little data is available in children.

CD8 response measured by QuantiFERON-TB Gold Plus and tuberculosis disease status.

Clinical application of the CD8 response as measured by the newer interferon gamma release assay, QuantiFERON-TB Gold-Plus (QFT-Plus), remains to be investigated.

Diagnostic accuracy of ESAT-6 free IGRA compared to QuantiFERON-TB Gold In-tube.

ESAT-6 is an immunodominant Mycobacterium tuberculosis (M.tb) antigen included in novel vaccines against tuberculosis (TB) as well as in IFN release assays (IGRA). Therefore, the availability of an ES...

Medical and Biotech [MESH] Definitions

None available.

More From BioPortfolio on "Anti-CMV Cellular Immunity Quantification Using an IGRA Test in Kidney Transplant récipients and Hemodialysis Patients, Comparison to Control Patients"

Quick Search


Searches Linking to this Trial